Daniel R Couriel

Trials

Studies that name Daniel R Couriel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:10 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02337517 · Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

  National Cancer Institute (NCI) · terminated · Chronic Graft Versus Host Disease · principal investigator
• Ph2
  NCT01028313 · A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease

  SCRI Development Innovations, LLC · withdrawn · Chronic Graft-Versus-Host Disease · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cancer Center Support Grant
  P30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI CORNELIA M ULRICH · fiscal years 2014 to 2026
  Named on NCT02337517